On the Selectivity of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Formation
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
301-316
Author(s):
Sabine Collaud, Asta Juzeniene, Johan Moan and Norbert Lange
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Journal:
Current Pharmacogenomics
Volume:
2
Page:
75-82
Author(s):
R. M. Phillips and S. Basu
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Journal:
Current Pharmacogenomics
Volume:
1
Page:
175-186
Author(s):
Jang-Ming Lee, Yung-Chie Lee, Chien-Jen Chen and Ming-Tsang Wu
Light Directed Gene Transfer by Photochemical Internalisation
Journal:
Current Gene Therapy
Volume:
3
Page:
89-112
Author(s):
A. Hogset, L. Prasmickaite, B. O. Engesaeter, M. Hellum, P. K. Selbo, V. M. Olsen, G. M. Maelandsmo and K. Berg
Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
511-519
Author(s):
A. Naldini, A. Pucci, C. Bernini and F. Carraro
Cancer Chemoprevention Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
45-54
Author(s):
K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone
Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Journal:
Current Drug Targets
Volume:
3
Page:
465-482
Author(s):
J.E. Trosko and R.J. Ruch
Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda